"Barbiturates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
| Descriptor ID |
D001463
|
| MeSH Number(s) |
D03.383.742.698.253
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Barbiturates".
Below are MeSH descriptors whose meaning is more specific than "Barbiturates".
This graph shows the total number of publications written about "Barbiturates" by people in this website by year, and whether "Barbiturates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Barbiturates" by people in Profiles.
-
Dasgupta I, Meadowcroft AM, Bhatt PR, Acharya A, Aarup M, Correa-Rotter R, Gupta S, Kher VK, Neto OMV, Rastogi A, Ots-Rosenberg M, Rayner B, Wong MG, Shah S, Taft L, Singh AK. Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial. Nephrol Dial Transplant. 2025 Jun 30; 40(7):1332-1341.
-
Kraft WK, Stover MW, Davis JM. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant. Semin Perinatol. 2016 Apr; 40(3):203-12.
-
Biedenbach DJ, Huband MD, Hackel M, de Jonge BL, Sahm DF, Bradford PA. In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens. Antimicrob Agents Chemother. 2015 Oct; 59(10):6053-63.
-
Yeakel JK, Logan BK. Butalbital and driving impairment. J Forensic Sci. 2013 Jul; 58(4):941-5.
-
Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study. Headache. 2012 Apr; 52(4):530-43.
-
Tepper SJ, Tepper DE. Breaking the cycle of medication overuse headache. Cleve Clin J Med. 2010 Apr; 77(4):236-42.
-
Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther. 2008 Apr; 33(2):141-51.
-
Young WB, Siow HC. Should butalbital-containing analgesics be banned? Yes. Curr Pain Headache Rep. 2002 Apr; 6(2):151-5.
-
Silberstein SD, McCrory DC. Butalbital in the treatment of headache: history, pharmacology, and efficacy. Headache. 2001 Nov-Dec; 41(10):953-67.
-
Kenton EJ. Diagnosis and treatment of concomitant hypertension and stroke. J Natl Med Assoc. 1996 Jun; 88(6):364-8.